Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: annual report findings
Reply New Message
Prev Message Back To Forum Threaded View Next Message

our goal is to advance MIE-101 into veterinary studies in 2022

Our goal aka Our Wishful Dream

 

and into Phase I clinical trials in 2023,

Our Goal again - another wishful dream

 

provided we are able to raise sufficient funding.

sufficient funding - aka if we can find Investors to buy our Stock

 

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply